The 21-aminosteroid tirilazad mesylate can ameliorate inflammatory bowel disease in rats

Journal of Pharmacology and Experimental Therapeutics

Volumn 276, Issue 1, 1996, Pages 265-270

  Yue, Gang ^a   Sun, Frank F ^b   Dunn, Colin ^b   Yin, Kingsley ^a   Wong, Patrick Y K ^a  

^a UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY   (United States)

^b PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MYELOPEROXIDASE; SUPEROXIDE; TIRILAZAD;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; DRUG EFFECT; ENTERITIS; ENZYME ACTIVITY; ENZYME REGULATION; INFLAMMATORY INFILTRATE; INTRAGASTRIC DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; ANTIOXIDANTS; BODY WEIGHT; CHEMILUMINESCENT MEASUREMENTS; COLITIS; COLON; FREE RADICAL SCAVENGERS; INFLAMMATORY BOWEL DISEASES; LIPID PEROXIDES; MALE; ORGAN SIZE; PEROXIDASE; PREGNATRIENES; RATS; RATS, SPRAGUE-DAWLEY; SUPEROXIDES; TRINITROBENZENESULFONIC ACID;

EID: 0029988763     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. ALLGAYER, H., HOFER, P., SCHMIDT, M., BOHNE, P., KRUIS, W. AND GUGLER, R.: Superoxide, hydroxyl and fatty acid radical scavenging by aminosalicylates. Direct evaluation with electron spin resonance spectroscopy Biochem. Pharmacol. 43: 259-262, 1992.
2. BAUER, M., BECKMAN, J. S., BRIDGES, R. AND MATALON, S : Peroxynitrite inhibits sodium transport in rat colonic mebrane vesicles. Biochem. Biophys. Acta 1104: 84-87, 1992.
3. BECKMAN, J. S , BECKMAN, T. W., CHEN, J., MARSHALL, P. A. AND FREEMAN, B. A.: Apparent hydroxyl radical production by peroxynitrite: Implications for endothelial injury from nitric oxide and superoxide. Proc. Natl Acad. Sci. USA 87: 1620-1624, 1990.
4. BLAKE, D. R., ALLEN, R. E. AND LUNEC, J.: Free radicals in biological systems - A review oriented to inflammatory processes. Br. Med. Bull. 43: 371-385, 1987.
5. BRADLEY, P. P., PRIEBAT, D. A., CHRISTENSEN, R. D. AND ROTHSTEIN, G.: Measurement of cutaneous inflammation: Estimation of neutrophil content with an enzyme marker. J. Invest. Dermatol. 78: 206-209, 1982.
6. BRAUGHLER, J. M., PREGENZER, J. F., CHASE, R. L., DUNCAN, L. A., JACOBSEN, E. J. AND MCCALL, J. M.: Novel 21-amino steroids as potent inhibitors of iron-dependent lipid peroxidation. J. Biol. Chem. 262: 10438-10440, 1987.
7. COSENZA, C. A., CRAMER, D. V., CUNEEN, S. A., TUSO, P. J , WANG, H. K. AND MAKOWKA, L.: Protective effect of the Lazaroid U74006F in cold ischemia-reperfusion injury of the liver. Hepatology 19: 418-425, 1994.
8. DULL, B. J., SALATA, K., VAN LANGENHOVE, A. AND GOLDMAN, P.: 5-aminosalicylate: Oxidation by activated leukocytes and protection of cultured cells from oxidative damage. Biochem. Pharmacol. 36: 2467-2472, 1987.
9. GRANGER, D. N., BENOIT, J. N., SUZUKI, M. AND GRISHAM, M. B.: Leukocyte adherence to venular endothelium during ischemia-reperfusion. Am. J. Physiol. 257: G683-G688, 1989.
10. GRISHAM, M. B. AND GRANGER, D. N.: Neutrophil-mediated mucosal injury. Role of reactive oxygen metabolites. Dig. Dis. Sci. 33; 6S-15S, 1988.
11. GRISHAM, M. AND MCCORD, J.: Chemistry and cytotoxicity of reactive oxygen metabolites. In Physiology of Oxygen Radicals, ed. by A. Taylor, S. Matalon and P. Ward, pp. 1-18, American Physiological Society, Bethesda, MD, 1986.
12. GRISHAM, M. B., RYAN, E. AND VON RITTER, C.: The aminosalicyclic acid scavenges hydroxyl radical and inhibits myeloperoxide activity. Gastroenterology 92: A1416, 1987.
13. HALL, E. D., PAZARA, K. E. AND BRAUGHLER, J. M.: 21-Aminosteroid lipid peroxidation inhibitor U74006F protects against cerebral ischemia in gerbils. Stroke 19: 997-1002, 1988.
14. KESHAVASZIAN, A., SEDGHI, S., KANOFSKY, J., LIST, T., ROBINSON, C., IBRAHIM, C. AND WINSHIP, D.: Excessive production of reactive oxygen metabolites by inflamed colon: Analysis by chemiluminescence probe. Gastroenterology 103: 177-185, 1992.
15. INAUEN, W., BILZER, M., ROWEDDER, E., HALTER, F. AND LAUTERBURG, B. H.: Decreased glutathione (GSH) in colonic mucosa of patients with inflammatory bowel disease: Mediated by oxygen free radicals (Abstract). Gastroenterology 94: A199, 1988.
16. ISCHIROPOULOS, H., ZHU, L. AND BECKMAN, J. S.: Peroxynitrite formation from macrophage-derived nitric oxide. Arch. Biochem. Biophys. 298: 446-451, 1992.
17. MILLER, M. J. S., SADOWSKA-KRAWICKA, H., CHOINARUEMOL, S., KAKKIS, J. L. AND CLARK, D. A.: Amelioration of chronic ileitis by nitric oxide synthase inhibition. J. Pharmacol. Exp. Ther. 264: 11-16, 1993.
18. MORRIS, G. P., BECK, P. L., HERRIDGE, M. S., DEPEW, W., SZEWCZUK, M. E. AND WALLACE, J. L.: Hapten-induced model of chronic inflammation and ulceration in the rat colon. Gastroenterology 96: 795-803, 1989.
19. MULDER, T. P. J., VERSPAGET, H. W., JANSSENS, A. R , PENA, A. S., GRIFFIOEN, G , WETERMAN, I. T. AND LAMERS, C. B. H. W.: Decreased levels of anti-oxidant proteins in the intestinal mucosa of patients with inflammatory bowel disease (IBD) (Abstract) Gut 31: A465, 1990.
20. NIELSEN, O. H., BERILD, D. AND AHNFELT-RONNE, I.: In vitro superoxide production by peripheral neutrophils from patients with inflammatory bowel disease. Mediat. Inflam. 3: 161-164, 1994.
21. 4 from activated neutrophils. Gut 28: 181-185, 1987.
22. PODRAZIK, R. M., OBEDIAN, R. S., REMICK, D G., ZELENOCK, G. B. AND D'ALECY, L G.: Attenuation of structural and functional damages from acute renal ischemia by the 21-aminosteroid U74006F in rats. Curr. Surg. 46: 287-292, 1989.
23. RAMPTON, D. S. AND HAWKEY, C. J.: Prostaglandins and ulcerative colitis. Gut 25: 1399-1413, 1984.
24. 2. Implications for the action of endothelium-derived relaxing factor (EDRF). Free Radic Res. Commun. 10: 221-226, 1990.
25. SCHUMBERT, R., TOWNER, J. AND ZIPSER, R. D.: Role of eicosanoids in human and experimental colitis. Dig. Dis. Sci. 33: 58S-64S, 1988.
26. SIMMONDS, N. J., ALLEN, C. R., STEVENS, T. R., VAN SOMEREN, R. N. M., BLAKE, D R. AND RAMPTON, D. S.: Chemiluminescence assay of mucosal reactive oxygen metabolites in inflammatory bowel disease. Gastroenterology 103: 186-196, 1992.
27. 4 in inflammatory bowel disease. In Inflammatory Bowel Disease - Basic Research and Clinical Implications, ed. by H. Goebell, B. M. Peskar and H. Malchow, pp. 143-152, Lancaster, UK: MTP Press, 1988.
28. SUEMATSU, M., SUZUKI, M., MIURA, S., NAGATA, H., OSHIO, C., ASAKURA, H., WATANABE, M. AND TSUCHIYA, M.: Sulfasalazine and its metabolites attenuate respiratory burst by leukocytes: A possible mechanism of anti-inflammatory effects. J. Clin. Lab. Immunol. 23: 31-33, 1987.
29. VON RITTER, C., GRISHAM, M. B. AND GRANGER, D. N.: Dulfasalazine metabolites and dapsone attenuate formyl-methiony-leucyl-phenyl-alanine-induced mucosal injury in rat ileum. Gastroenterology 96: 811-816, 1989.
30. WEISS, S. J.: Tissue destruction by neutrophils. N Engl. J. Med. 320: 365-376, 1989.